Global Brain Tumor Diagnosis And Treatments Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product Type;

Primary Brain Tumor - Meningioma, Gliomas, Astrocytomas, Pituitary Tumors and Others, Secondary Brain Tumor.

By Product Analysis;

Stains and Varnishes, Shellacs, Lacquers, and Others.

By Diagnosis Type;

CT Scan, MRI, PET-CT Scan, Molecular Testing, EEG and Others.

By Treatment Type;

Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn135206878 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Brain Tumor Diagnosis And Treatments Market (USD Million), 2021 - 2031

In the year 2024, the Global Brain Tumor Diagnosis And Treatments Market was valued at USD 908.35 million. The size of this market is expected to increase to USD 1,393.11 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.3%.

The global brain tumor diagnosis and treatments market is poised for significant growth due to the rising incidence of brain tumors, advancements in diagnostic technologies, and the increasing availability of effective treatment options. Brain tumors, both malignant and benign, require precise diagnosis and timely treatment to improve patient outcomes. The growing awareness about early diagnosis and the availability of advanced imaging techniques such as MRI, CT scans, and PET scans have greatly enhanced the ability to detect brain tumors at earlier stages, thereby increasing the demand for diagnostic tools and services.

The market is also driven by the continuous advancements in treatment modalities, including surgical procedures, radiation therapy, chemotherapy, and targeted drug therapies. Innovations in minimally invasive surgical techniques and the development of more effective radiotherapy equipment have improved the success rates and reduced the side effects of treatments. The advent of personalized medicine and targeted therapies tailored to the genetic profile of individual tumors has opened new avenues for more effective and less toxic treatment options, driving the growth of the market.

North America and Europe dominate the global brain tumor diagnosis and treatments market due to their well-established healthcare infrastructure, high healthcare expenditure, and the presence of key market players. However, emerging economies in Asia-Pacific are expected to witness substantial growth owing to increasing healthcare investments, improving healthcare infrastructure, and rising awareness about advanced diagnostic and treatment options. The market is characterized by intense competition, with major players focusing on research and development to introduce innovative products and expand their market presence through strategic collaborations and acquisitions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Product Analysis
    3. Market Snapshot, By Diagnosis Type
    4. Market Snapshot, By Treatment Type
    5. Market Snapshot, By Region
  4. Global Brain Tumor Diagnosis And Treatments Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Incidence
        2. Advanced Diagnostics
        3. Treatment Innovations
      2. Restraints
        1. High costs
        2. Limited accessibility
        3. Technological limitations
      3. Opportunities
        1. Early Diagnosis
        2. Advanced Imaging
        3. Minimally Invasive
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Brain Tumor Diagnosis And Treatments Market, By Product Type, 2021 - 2031 (USD Million)
      1. Primary Brain Tumor
        1. Meningioma
        2. Gliomas
        3. Astrocytomas
        4. Pituitary Tumors
        5. Others
      2. Secondary Brain Tumor
    2. Global Brain Tumor Diagnosis And Treatments Market, By Product Analysis, 2021 - 2031 (USD Million)
      1. Stains and Varnishes
      2. Shellacs
      3. Lacquers
      4. Others
    3. Global Brain Tumor Diagnosis And Treatments Market, By Diagnosis Type, 2021 - 2031 (USD Million)
      1. CT Scan
      2. MRI
      3. PET-CT Scan
      4. Molecular Testing
      5. EEG
      6. Others
    4. Global Brain Tumor Diagnosis And Treatments Market, By Treatment Type, 2021 - 2031 (USD Million)
      1. Surgery
      2. Radiation Therapy
      3. Targeted Therapy
      4. Chemotherapy
      5. Immunotherapy
    5. Global Brain Tumor Diagnosis And Treatments Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Pfizer, Inc.
      2. Toshiba Medical Systems
      3. GE Healthcare
      4. AstraZeneca
      5. Merck & Co., Inc.
      6. Siemens Healthineers
      7. Carestream Health
      8. Hitachi Medical Corporation
      9. Philips Healthcare
  7. Analyst Views
  8. Future Outlook of the Market